Kusukela ekuxazululeni izinkinga kuya ekwenzeni izinqumo, sidinga ukwazi ukuqonda, ukuhlaziya nokuhumusha ulwazi ngempumelelo. Njengoba ubuchwepheshe kanye nocwaningo lwesayensi kuqhubeka, amathuba okuthuthukisa amakhono ethu okuqonda ayanda, okuholela emiphumeleni emangalisayo.
Amakhono okuqonda athuthukisiwe angaba nomthelela kuzo zonke izici zokuphila kwethu, okuhlanganisa imfundo, ukukhula kobungcweti kanye nentuthuko yomuntu siqu. Umuntu onekhono lokuqonda elithuthukisiwe angaqonda ngokushesha imiqondo, agcine ulwazi, futhi alusebenzise ezimweni ezintsha. Lokhu kubonisa amazinga aphezulu okudala, ukucabanga okubucayi kanye namakhono okuxazulula izinkinga.
Ngaphezu kwalokho, abantu abathuthukisa amakhono okuqonda emsebenzini bavame ukwenza kahle emisebenzini yabo. Basebenza kahle futhi bavumelana nezimo, bayakwazi ukusingatha imisebenzi eyinkimbinkimbi. Ukunaka kwabo okujulile emininingwaneni kubavumela ukuthi benze ukuxhumana okunenjongo futhi bahlaziye ulwazi ngokunemba.
Ucwaningo luye lwabonisa ukuthi abantu abanamakhono okuqonda athuthukisiwe banokulawula okungcono ngokomzwelo kanye nokuqina. Bangakwazi ukuphatha ngempumelelo ukucindezeleka, ukukhathazeka, kanye nokucindezeleka ngokusebenzisa amasu okuqonda ukuze bahlele kabusha imicabango emibi futhi bahlele kabusha imibono yezimo eziyinselele.
Kodwa-ke, kubalulekile ukuphatha ukuthuthukiswa kwengqondo ngokuqapha. Nakuba intuthuko kwezobuchwepheshe inikeze amathuluzi amaningi kanye nesofthiwe yokuthuthukisa amakhono okuqonda, kubalulekile futhi ukugcina ibhalansi. Ubuchopho bomuntu buyisitho esiyinkimbinkimbi, futhi ukuthembela ngokweqile kubuchwepheshe kungalimaza amakhono ethu okuqonda emvelo. Kubalulekile ukuqhubeka nemisebenzi esebenzisa ngokwemvelo umsebenzi wokuqonda, njengokufunda, ukufunda amakhono amasha, kanye nokugcina ukuxhumana nabantu.
I-Sunifiram, eyaziwa nangokuthi i-DM-235, iyinhlanganisela ye-nootropic engaphansi kwesigaba se-ampakin futhi iyi-derivative ye-piracetam. Ekuqaleni yasungulwa abacwaningi baseJapan, i-Sunifiram isithandwa kakhulu ngezakhiwo zayo zokuthuthukisa ukuqonda. Ifana ngokwesakhiwo nezinye izinto ezifana ne-piracetam ne-aniracetam, kodwa inendlela ehlukile yokusebenza.
I-Sunifiram isebenza ngokuyinhloko ngokugxila kuma-receptor athile ebuchosheni abizwa ngokuthi ama-AMPA receptors. Ngokubopha nokwandisa umsebenzi wala ma-receptor, i-Sunifiram ithuthukisa ukukhishwa kwe-glutamate, i-neurotransmitter ehilelekile enqubweni yokufunda nenkumbulo. Lokhu kwanda kokukhishwa kwe-glutamate kukholakala ukuthi kuyimbangela yemiphumela ye-nootropic ye-Sunifiram.
1. Thuthukisa ukugxilisa ingqondo
Kuthuthukisa ukugxila futhi kuthuthukisa ukugxila. Ngokukhuthaza ukukhululwa kwe-glutamate, i-neurotransmitter evuselelayo, kwenza ubuchopho bukwazi ukucubungula ulwazi ngendlela ephumelela kakhulu. Lokhu kugxila okujulile kungakhulisa kakhulu umkhiqizo kanye nokucaca komcabango, futhi ngenxa yalokho, abantu bangase bathole umkhiqizo owandisiwe kanye nokusebenza kwengqondo iyonke.
2. Thuthukisa inkumbulo kanye nekhono lokufunda
I-Sunifiram ineamandla okuthuthukisa inkumbulo nokuthuthukisa ukufundaUcwaningo lusikisela ukuthi lungakhuthaza amandla esikhathi eside, inqubo eyisisekelo sokwakheka kwenkumbulo kanye ne-synaptic plasticity, okuthuthukisa ukugcinwa kwenkumbulo futhi kuthuthukise ikhono lethu lokufunda nokucubungula ulwazi ngempumelelo. Ucwaningo lubonisa ukuthi i-Sunifiramkungathuthukisa inkumbulo ngokwandisa ukukhishwa kwe-acetylcholine, i-neurotransmitter ebalulekile ekusebenzeni kwenkumbulo.
3. Kukhulisa amandla engqondo kanye nokukhuthazela
Ezweni lethu elisheshayo, ukukhathala kwengqondo kuvame kakhulu. Njengoba kungenzeka ukuthi kukhuliswe amazinga amandla engqondo kanye nokukhuthazela, i-sunifiram inesithembiso esikhulu kulabo abafuna ukulwa nokukhathala nokugcina izingqondo zabo zibukhali. Ngokuvuselela ama-receptor e-glutamate, i-Sunifiram ithuthukisa ukusebenza kahle kwamandla ebuchosheni, ikhuthaza kakhulu ukuqwashisa kwengqondo futhi ithuthukise ukusebenza kwengqondo iyonke.
4. Ukuphakamisa Imizwa Nokugqugquzeleka
Izinzuzo ze-Sunifiram azigcini nje ngokuthuthukiswa kwengqondo; le nhlanganisela ingaba nomthelela omuhle emazingeni ethu emizwa kanye nogqozi. Kukholakala ukuthi isebenzisa ama-receptor e-dopamine ebuchosheni ahlotshaniswa nenjabulo kanye nogqozi. Ngenxa yalokho, abantu bangase bazizwe benogqozi olwengeziwe, isimo sengqondo esithuthukisiwe, kanye nokuzimisela okukhulu kokuzibandakanya emisebenzini enzima.
5. Amandla okuvikela izinzwa
Ngaphezu kwezinzuzo zayo zokuqonda, i-Sunifiram inamandla okuvikela amangqamuzana ezinzwa ekulimaleni okubangelwa ukucindezeleka kwe-oxidative noma ukwehla kwengqondo okuhlobene nobudala. Ngokukhuthaza ukukhiqizwa kwe-nerve growth factor (NGF) kanye ne-brain-derived neurotrophic factor (BDNF), i-Sunifiram ingabonisa izakhiwo zokuvikela izinzwa, ngaleyo ndlela ikhuthaze ukusebenza kobuchopho okunempilo futhi yandise isikhathi sokuphila.
Ukuqhathanisa i-Sunifiram nezinye izidakamizwa ze-nootropic ezifana ne-Modafinil, i-Aniracetam, ne-Noopept kwembula ukufana nokwehluka okuthile.
I-Modafinil ivame ukusetshenziswa ekwelapheni i-narcolepsy kanye nezinkinga zokulala, futhi ivame ukusetshenziswa ngaphandle kwegama layo njengesithuthukisi sokucabanga. Nakuba ingavuselela ingqondo futhi ithuthukise ukugxila, ihlose kakhulu ama-neurotransmitter obuchopho akhuthaza ukuvuka, ishiye eminye imisebenzi yokucabanga ingathinteki kangako.
Ngakolunye uhlangothi, i-Sunifiram iklanyelwe ngokukhethekile ukuthuthukisa inkumbulo nokufunda. Ukugxila kwayo kuma-receptor e-glutamate kuyivumela ukuthi ithuthukise imisebenzi yayo eyinhloko yokuqonda. Lokhu kwenza i-Sunifiram ibe ukukhetha okufanele kubantu abahlose ukuthuthukisa inkumbulo iyonke kanye namakhono okuqonda.
I-Aniracetam ingenye i-nootropic ethandwayo esebenza kuma-receptor e-acetylcholine ebuchosheni, okuthuthukisa ukugxila nokucaca komcabango. Nakuba i-Sunifiram ingenakho ukusebenzisana okuqondile nama-receptor e-acetylcholine, isenzo sayo kuma-receptor e-glutamate sibikwe ukuthi sithuthukisa isikhathi sokunaka kanye nomsebenzi wokuqonda jikelele, okwenza kube yindlela ehlukile ewusizo.
I-Noopept iyintsha ezweni le-nootropic, eyaziwa ngezakhiwo zayo zokuvikela imizwa. Ikhuthaza impilo yobuchopho ngokukhulisa i-nerve growth factor (NGF), edlala indima ebalulekile ekugcinweni nasekukhuleni kwama-neurons. I-Sunifiram, nakuba ingahlobene ngqo nokukhuthazwa kwe-NGF, ingase isekele impilo yobuchopho ngokungaqondile ngemiphumela yayo kuma-receptor e-glutamate.
Ngaphezu kwalokho, imiphumela ye-Sunifiram ivame ukuba yesikhashana, ithuthukisa ukusebenza kwengqondo zingakapheli amahora ambalwa. Lokhu kungabonakala njengenzuzo kanye nokungalungi, njengoba kuvumela abantu ukuthi babone ukuthuthuka okusheshayo ekusebenzeni kwengqondo, kodwa kungadinga umthamo ovamile ukuze kuzuze njalo.
I-Sunifiram iyinhlanganisela entsha kakhulu enocwaningo olulinganiselwe ngemiphumela yayo yesikhathi eside kanye nokuphepha. Kodwa-ke, imibiko emfushane evela kubasebenzisi iqokomisa eminye imiphumela emibi engaba khona okufanele icatshangelwe.
Omunye wemiphumela emibi evame kakhulu ikhanda elibuhlungu. Abanye abantu baba nekhanda elibuhlungu elincane kuya kwelibi ngemva kokuthatha i-Sunifiram. Lokhu kungabangelwa umphumela onamandla wokuvuselela wenhlanganisela ohlelweni lwezinzwa. Uma uzwa ubuhlungu bekhanda ngenkathi usebenzisa i-Sunifiram, kunconywa ukuthi wehlise umthamo wakho noma uyeke ukuwusebenzisa ngokuphelele.
Omunye umphumela ongase ube khona we-Sunifiram ukukhathazeka noma ukungahlaliseki. Abanye abasebenzisi babika ukuthi bazizwa bekhathazekile noma bekhathazekile ngemva kokuthatha le nhlanganisela. Lokhu kungase kube ngenxa yekhono le-Sunifiram lokukhulisa ukukhishwa nokumuncwa kwama-neurotransmitter athile ebuchosheni, njenge-glutamate. Uma uthambekele ekukhathazekeni noma unomlando wezinkinga zokukhathazeka, kuyalulekwa ukuthi usebenzise i-Sunifiram ngokuqapha noma uthintane nochwepheshe wezempilo ngaphambi kokusebenzisa.
Omunye umphumela omubi obikwe abanye abasebenzisi be-Sunifiram ukungakwazi ukulala noma ukuba nenkinga yokulala. Izakhiwo ezivuselelayo zalesi sakhi zingaphazamisa amaphethini okulala, zenze kube nzima ukulala noma ukuhlala ulele ubusuku bonke.
Ezimweni ezingavamile, abantu baye babika izinkinga zokugaya ukudla ezifana nokuphazamiseka kwesisu noma isifo sohudo ngemuva kokuthatha i-Sunifiram. Nakuba le miphumela emibi ingavamile, akufanele inganakwa. Uma uhlangabezana nokucindezeleka okuqhubekayo kwesisu ngenkathi usebenzisa le nhlanganisela, kuyalulekwa ukuthi uyeke ukuyisebenzisa futhi uthintane nochwepheshe wezempilo ukuze kususwe noma yiziphi izinkinga zezokwelapha eziyisisekelo.
Ekuphetheni, yize i-Sunifiram inganikeza izinzuzo zokuqonda ezingaba khona, umuntu kumele aqaphele imiphumela emibi engaba khona. Lokhu kufaka phakathi ikhanda, ukukhathazeka noma ukungaphumuli, izinkinga zokulala, nezinkinga zokugaya ukudla. Uma ucabanga nge-Sunifiram, kungcono ukuqala ngomthamo ophansi bese uqaphela impendulo yomzimba wakho ngokucophelela. Ukubonisana nochwepheshe wezempilo kuhlale kunconywa, ikakhulukazi uma unezimo zezokwelapha ezikhona noma uthatha eminye imithi. Njenganoma yimuphi umuthi we-nootropic noma isengezo, ukusetshenziswa okunesibopho kanye nokuzazi komuntu siqu kubalulekile ekufinyeleleni ukuthuthukiswa kokuqonda okufiselekayo ngenkathi kunciphisa imiphumela emibi engaba khona.
Q: Isebenza kanjani i-Sunifiram?
A: I-Sunifiram kukholakala ukuthi isebenza ngokwandisa umsebenzi wama-neurotransmitter ebuchosheni, njenge-acetylcholine ne-glutamate. Ingase futhi ithuthukise ukukhishwa kwe-GABA, i-neurotransmitter ebhekene nokunciphisa ukukhathazeka nokukhuthaza umuzwa wokuzola.
Q: Kuthatha isikhathi esingakanani ukuthi i-Sunifiram ibonise imiphumela?
A: Ukuqala kwemiphumela kungahluka kumuntu nomuntu. Abanye abantu bangase babe nemiphumela ebonakalayo esikhathini esifushane, kanti abanye bangadinga isikhathi eside sokusetshenziswa njalo. Kubalulekile ukubekezela nokunikeza inhlanganisela isikhathi esanele sokusebenzisa imiphumela yayo engaba ngcono yokuthuthukisa ingqondo.
Isixwayiso: Lesi sihloko senzelwe ulwazi kuphela futhi akufanele sibhekwe njengeseluleko sezokwelapha. Njalo xhumana nochwepheshe wezempilo ngaphambi kokusebenzisa noma yiziphi izithasiselo noma ukushintsha uhlelo lwakho lwezempilo.
Isikhathi sokuthunyelwe: Agasti-07-2023
